Two new indications for pembrolizumab have been approved in Russia
.
Saved in:
| Main Author: | article Editorial |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-11-01
|
| Series: | Опухоли женской репродуктивной системы |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/739 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New indications for the use of pembrolizumab in Russia: the use of the drug in the 1st line of treatment of recurrent and metastatic head and neck squamous cell carcinoma in single mode and in combination with chemotherapy has been approved
by: Article Editorial
Published: (2020-11-01) -
Proceedings of the Expert Council “Treatment of inoperable endometrial cancer in Russia: issues that have not yet been addressed”
by: article Editorial
Published: (2021-06-01) -
The drug for repletion of the lack of growth hormone has been approved in the United States
by: article Editorial
Published: (2023-08-01) -
The two members from the “Obstetrics, Gynecology and Reproduction” Editorial Board have been elected as Foreign Members of the Russian Academy of Sciences
by: Article Editorial
Published: (2022-07-01) -
The world's first topical gene therapy drug for epidermolysis bullosa patients has been approved
by: article Editorial
Published: (2023-07-01)